Search Results - "Tammara, V"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    A comparison of two sparse sampling population pharmacokinetic approaches for the estimation of pharmacokinetic parameters in children by Mahmood, I, Tammara, V

    “…The objectives of this study were to assess pharmacokinetic parameters (clearance, volume and half-life) in children using sparse sampling population as well…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetic-Pharmacodynamic Modeling of Rivastigmine, a Cholinesterase Inhibitor, in Patients with Alzheimer's Disease by Gobburu, J.V.S., Tammara, V, Lesko, L, Jhee, S. S., Sramek, J. J., Cutler, N. R., Yuan, Ruihua

    Published in Journal of clinical pharmacology (01-10-2001)
    “…Rivastigmine is a cholinersterase inhibitor approved recently for the treatment of Alzheimer's disease (AD). The objective of this study is to characterize the…”
    Get full text
    Journal Article
  3. 3

    Does percent reduction in seizure frequency correlate with plasma concentration of anticonvulsant drugs? Experience with four anticonvulsant drugs by Mahmood, Iftekhar, Tammara, Vijay K., Baweja, Raman K.

    Published in Clinical pharmacology and therapeutics (01-11-1998)
    “…Objective To investigate the relationship between the percentage reduction in seizure frequency in patients with epilepsy and plasma concentrations after oral…”
    Get full text
    Journal Article
  4. 4

    Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation by Tammara, V K, Narurkar, M M, Crider, A M, Khan, M A

    Published in Journal of pharmaceutical sciences (01-05-1994)
    “…Morpholinoalkyl esters (HCl salts) of diclofenac (1) were synthesized and evaluated in vitro and in vivo for their potential use as prodrugs for oral delivery…”
    Get more information
    Journal Article
  5. 5

    Synthesis and evaluation of morpholinoalkyl ester prodrugs of indomethacin and naproxen by Tammara, V K, Narurkar, M M, Crider, A M, Khan, M A

    Published in Pharmaceutical research (01-08-1993)
    “…Morpholinoalkyl esters (HCl salts) of naproxen 1 and indomethacin 3 were synthesized and evaluated in vitro and in vivo for their potential use as prodrugs for…”
    Get full text
    Journal Article
  6. 6

    Pharmacokinetic-Pharmacodynamic Modeling of Rivastigmine, a Cholinesterase Inhibitor, in Patients with Alzheimer's Disease by Gobburu, JVS, Tammara, V, Lesko, L, Jhee, S S, Sramek, J J, Cutler, N R, Yuan, Ruihua

    Published in Journal of clinical pharmacology (01-10-2001)
    “…Rivastigmine is a cholinersterase inhibitor approved recently for the treatment of Alzheimer's disease (AD). The objective of this study is to characterize the…”
    Get full text
    Journal Article
  7. 7

    A Limited sampling approach in bioequivalence studies by MAHMOOD, I, CHAMBERLIN, N, TAMMARA, V

    Published in Therapeutic drug monitoring (01-08-1997)
    “…A limited sampling model (LSM) has been developed for an antidepressant immediate-release product (Drug A) and an antiepileptic controlled release product…”
    Get full text
    Journal Article
  8. 8

    A limited sampling method for the estimation of vigabatrin maximum plasma concentration and area under the curve by TAMMARA, V, MAHMOOD, I, YU, D. K, HILEMAN, G. A

    Published in Therapeutic drug monitoring (01-02-1997)
    “…A limited sampling model (LSM) was developed to estimate the area under the curve (AUC) and maximum plasma concentration (Cmax) for a 1-g oral dose of…”
    Get full text
    Journal Article
  9. 9
  10. 10